Yao-Ting Huang

Publications (3)5.95 Total impact

• Source

  Available from: Chien-Shun Chiou

  Article: MPTP-induced dopaminergic degeneration and deficits in object recognition in rats are accompanied by neuroinflammation in the hippocampus.

  Hiu-Ngar Sy, Shey-Lin Wu, Wen-Fu Wang, Chang-Hao Chen, Yao-Ting Huang, Ying-Ming Liou, Chien-Shun Chiou, Cornelius Rainer Pawlak, Ying-Jui Ho
  [show abstract] [hide abstract]
  ABSTRACT: Emotional changes, impairment of object recognition, and neuroinflammation are seen in Parkinson's disease with dementia (PDD). Here, we show that bilateral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) into the rat substantia nigra pars compacta (SNc) of Wistar rats caused degeneration of nigrostriatal dopaminergic neurons, microglial activation in the SNc and hippocampus, and cell loss in the hippocampal CA1 area. With regard to behavior, an increase in anxiety-like behavior and impairment of object recognition were observed during the fourth week after MPTP lesioning. The behavioral changes were not caused by motor impairment, since the rats had already recovered from MPTP-induced catalepsy before the tests were performed. These findings show that MPTP-induced neuroinflammation and its consequences, for example, microglial activation and cell loss in the hippocampus, may be involved in dopaminergic degeneration-related behavioral deficits and suggest that, in addition to the dopaminergic system, the limbic system may also participate in the pathophysiology of PDD. MPTP-lesioned rats are therefore proposed as a useful tool for assessing the ability of pharmacological agents to prevent recognition deficits in PDD.
  Pharmacology Biochemistry and Behavior 04/2010; 95(2):158-65. · 2.53 Impact Factor
• Article: [Beyond the psychometric assessments: the evaluation of patients with Alzheimer's disease].

  Wen-Fu Wang, Chuan-Ju Wang, Yao-Ting Huang
  [show abstract] [hide abstract]
  ABSTRACT: Alzheimer's disease is a neurodegenerative illness. The Mini Mental State Examination (MMSE), Cognitive Abilities Screening Instrument (CASI) and Clinical Dementia Rating (CDR) are applied to assess whether a person suffers Alzheimer's disease and determine its severity. There are many confounding factors within those assessments, medical professionals need to bear in mind the pitfalls when evaluating the data and the patient.
  Acta neurologica Taiwanica 03/2010; 19(1):70-5.
• Source

  Available from: csmu.edu.tw

  Article: Effects of D-cycloserine on the behavior and ERK activity in the amygdala: role of individual anxiety levels.

  Shey-Lin Wu, Li-Sung Hsu, Wei-Ting Tu, Wen-Fu Wang, Yao-Ting Huang, Cornelius Rainer Pawlak, Ying-Jui Ho
  [show abstract] [hide abstract]
  ABSTRACT: Low dose of D-cycloserine (DCS), a partial agonist of glycine binding site on N-methyl-D-aspartate (NMDA) receptors, can facilitate extracellular signal-regulated kinase1/2 (ERK1/2) activity in the amygdala and modulate emotional behavior. However, the relationship between ERK1/2 activation, individual anxiety levels, and DCS is unknown. Therefore, based on open arm time in the elevated plus-maze, male Wistar rats were divided into subgroups with either low (LOA) or high open arm (HOA) time. Open arm time is usually accepted as a critical index of unconditioned anxiety-like/avoidance behavior. On the following day, DCS (30 mg/kg, i.p.) was administered 30 min before the second elevated plus-maze test. On day 8 and 9, the rats were subjected to a 2-day session of the forced swim test, receiving the DCS treatment again 30 min before the 2nd day. On the 16th day, 30 min after the administration of DCS, the rats were sacrificed in order to detect the phosphorylation of ERK1/2 (p-ERK1/2) in the amygdala by Western blots. The results showed that: (1) DCS decreased the open arm time in HOA but not LOA rats. (2) DCS suppressed the immobility in the day-2 trial of the forced swim test and increased the p-ERK1/2 level in the amygdala in LOA but not HOA rats. This is the first instance data has been found indicating different sensitivities of p-ERK1/2 and behavioral responses to the treatment of DCS between HOA and LOA rats. The results suggest that the activity of NMDA receptor-mediated ERK1/2 signaling is mediated by individual behavioral differences which are related to the antidepressant-like activity of DCS. This study provides first insight into the pathophysiological role of ERK signaling with regard to individual differences in emotional behavior.
  Behavioural Brain Research 04/2008; 187(2):246-53. · 3.42 Impact Factor